<?xml version="1.0" encoding="UTF-8"?>
<ref id="B117-vaccines-07-00203">
 <label>117.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Leung</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Schroder</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>White</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>N.X.</given-names>
   </name>
   <name>
    <surname>Stoermer</surname>
    <given-names>M.J.</given-names>
   </name>
   <name>
    <surname>Abbenante</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Martin</surname>
    <given-names>J.L.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>P.R.</given-names>
   </name>
   <name>
    <surname>Fairlie</surname>
    <given-names>D.P.</given-names>
   </name>
  </person-group>
  <article-title>Activity of recombinant dengue 2 virus NS3 protease in the presence of a truncated NS2B co-factor, small peptide substrates, and inhibitors</article-title>
  <source>J. Biol. Chem.</source>
  <year>2001</year>
  <volume>276</volume>
  <fpage>45762</fpage>
  <lpage>45771</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.M107360200</pub-id>
  <pub-id pub-id-type="pmid">11581268</pub-id>
 </element-citation>
</ref>
